SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-002791 to GLOBUS MEDICAL INC (GMED) (CIK 0001237831) (GMED)

GLOBUS MEDICAL INC (GMED) (CIK 0001237831)
Date: March 21, 2023 · CIK: 0001237831 · Accession: 0000000000-23-002791

AI Filing Summary & Sentiment

File numbers found in text: 333-270482

Date
March 21, 2023
Author
Not clearly detected
Form
UPLOAD
Company
GLOBUS MEDICAL INC (GMED) (CIK 0001237831)

Letter

United States securities and exchange commission logo March 21, 2023 Daniel Scavilla Chief Executive Officer and President Globus Medical, Inc. 2560 General Armistead Avenue Audubon, PA 19403-5214 Re:Globus Medical, Inc. Registration Statement on Form S-4 Filed March 13, 2023 File No. 333-270482 Dear Daniel Scavilla: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Jennifer Porter, Esq.

Show Raw Text
United States securities and exchange commission logo
March 21, 2023
Daniel Scavilla
Chief Executive Officer and President
Globus Medical, Inc.
2560 General Armistead Avenue
Audubon, PA 19403-5214
Re:Globus Medical, Inc.
Registration Statement on Form S-4
Filed March 13, 2023
File No. 333-270482
Dear Daniel Scavilla:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Jennifer Porter, Esq.